Pharmacoinvasive Strategy vs Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Study in Mexico City

BACKGROUND: A low proportion of patients with ST-elevation myocardial infarction (STEMI) in low- to middle-income countries receive reperfusion therapy. Although primary percutaneous coronary intervention (PCI) is the method of choice, a pharmacoinvasive strategy (PIs) is reasonable when primary PCI...

Descripción completa

Detalles Bibliográficos
Autores principales: Araiza-Garaygordobil, Diego, Gopar-Nieto, Rodrigo, Cabello-López, Alejandro, Martinez-Amezcua, Pablo, Eid-Lidt, Guering, Baeza-Herrera, Luis A., Gonzalez-Pacheco, Héctor, Briseño-De la Cruz, Jose Luis, Sierra-Lara Martinez, Daniel, Mendoza-García, Salvador, Altamirano-Castillo, Alfredo, Arias-Mendoza, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129473/
https://www.ncbi.nlm.nih.gov/pubmed/34027343
http://dx.doi.org/10.1016/j.cjco.2020.11.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129473/
https://www.ncbi.nlm.nih.gov/pubmed/34027343
http://dx.doi.org/10.1016/j.cjco.2020.11.012

Ejemplares similares